Despite this, the fact that all examined studies, albeit few in number, showed positive associations with the preclinical outcomes demonstrates the high potential for RAGE to serve as a biomarker that potently contribute to PCa tumorigenesis. This evidence concerns the gene AGER and posterior cortical atrophy.